Drug-Researcher Quintiles Looking at ’Tuck-In’ Deals

Quintiles Transnational Corp., the biggest provider of drug-trial services to pharmaceutical companies, may make acquisitions that are “tactical tuck-ins” as it grows organically, Chief Executive Officer Tom Pike said.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.